Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

IOM and Partners Launch Project to Strengthen Environmental Health Awareness in Lebanon

 
In cooperation with the Ministry of Public Health (MoPH) in Lebanon, the International Organization for Migration (IOM) together with Seed Global Health, has launched the “Environmental Health Capacity and Awareness Strengthening in Primary Healthcare Facilities” project. This initiative aims to empower healthcare workers at selected Primary Healthcare Centers (PHCCs) across Lebanon by addressing the growing challenges of climate-related health impacts.  

A recent study by the Lebanese Red Cross Climate Center found that climate change will have an important health impact in Lebanon. Rising temperatures and extreme weather events can lead to heat-related health risks, heatstroke, dehydration, or death which are higher in urban areas. Furthermore, climate change in Lebanon is expected to exacerbate water scarcity and quality due to increased droughts, intensified precipitation variability, and disrupted agriculture, leading to higher risks of waterborne diseases, malnutrition, and food insecurity, further straining the already fragile healthcare systems. 

The project, which will run from 2 January 2025 to 30 April 2025, is aligned with the Ministry of Public Health’s National Strategy and leverages interdisciplinary expertise to build resilience within the health sector. 

Dr. Firas Abiad, the Minister of Public Health in Lebanon stated: “Public, private and peripheral hospitals have proven their critical role during the Lebanese conflict, not only in providing care but also in addressing the broader health needs of the population. While the priority for international support to Lebanon remains the health sector, we must seize this opportunity to advance in all areas, including environmental health. Strengthening environmental health measures will ensure that facilities across Lebanon can provide safer, and more sustainable healthcare services. A resilient health system integrates environmental health into its foundations to safeguard the well-being of both residents of the region and the Lebanese population.”

Dr. Vanessa Kerry, CEO of Seed Global Health, said, “Health workers are our frontline defense against the impacts of climate change on health and it is crucial they are equipped with the necessary knowledge and skills to better understand and respond to these impacts. Seed Global Health is proud to partner with IOM and others to ensure people in Lebanon and elsewhere are better protected against the growing threat of climate change on health.” 

The project emphasizes a phased approach, beginning with a comprehensive needs assessment to evaluate the knowledge, attitudes, and practices (KAP) of PHCC staff regarding environmental health and climate change. Findings will inform tailored training programs, equipping healthcare workers with the tools and skills to respond effectively to climate-health challenges. Key activities include developing gender-sensitive and equity-focused survey tools, engaging stakeholders, and gathering actionable data to bridge gaps in preparedness and capacity. 

The project will be supported by technical experts from global and academic institutions, including the University of Melbourne and its Climate CATCH Lab, and involves active collaboration with local stakeholders such as the Ministry of Public Health, PHCC managers, and NGOs. 

“The intersection of climate change and health is an area where we must act quickly, to be prepared for the challenges that will come. IOM is proud to launch this initiative alongside our partners that will equip the Lebanese health sector with the tools they need to meet these challenges and support a healthier future for all people they serve,” explained Mathieu Luciano, IOM Head of Office for Lebanon. [GA1] 

About the Project 

This initiative reflects IOM’s commitment to addressing the intersection of climate change and health. The project’s key deliverables include a finalized needs assessment report, recommendations for future capacity-building initiatives, and a roadmap for sustained environmental health interventions. 

About Seed Global Health 

Seed Global Health partners with governments, health professional schools, hospitals, and clinics to educate health workers, strengthen the quality of health services, and support policies that enable health professionals to deliver high-quality services to those in need. To date, Seed Global Health has trained more than 45,000 health workers who work in health facilities serving over 76 million people. 

For more information, please contact: 
Communications Officer, IOM Lebanon 
(Name), (Email Address), (Phone Number) 
 
 [GA1]Moved Mathieu's quote here since having three together above was too much. It could also be deleted.
 
    1
ATC Name B/G Ingredients Dosage Form Price
A11CC05 UBSA-D G Vitamin D3 - 10,000IU 10,000IU Capsule, soft gelatin 935,570 L.L
N02BE01 UBSADOL BABY G Paracetamol - 120mg/5ml 120mg/5ml Suspension 168,940 L.L
N02BE01 UBSADOL CHILDREN'S G Paracetamol - 240mg/5ml 240mg/5ml Elixir 284,127 L.L
C10AA07 UBSATOR-CA G Rosuvastatin (calcium) - 10mg 10mg Tablet, film coated 499,142 L.L
C10AA07 UBSATOR-CA G Rosuvastatin (calcium) - 20mg 20mg Tablet, film coated 499,142 L.L
A02BC01 ULCAZAL G Omeprazole (sodium) - 40mg 40mg Injectable sterile lyophilised powder for solution 895,895 L.L
A02BC01 ULCAZAL G Omeprazole (sodium) - 40mg 40mg Injectable sterile lyophilised powder for solution 5,916,747 L.L
A03CA02 ULCEDEX G Clidinium bromide - 2.5mg, Chlordiazepoxide - 5mg Tablet 222,694 L.L
R03AL04 ULTIBRO BREEZHALER B Indacaterol - 110mcg, Glycopyronium - 50mcg Capsule, inhalation 4,031,528 L.L
N01AH06 ULTIVA B Remifentanil (HCl) - 5mg 5mg Injectable powder for solution 2,990,050 L.L
N01AH06 ULTIVA B Remifentanil (HCl) - 2mg 2mg Injectable powder for solution 1,632,769 L.L
A07FA02 ULTRA LEVURE B Saccharomyces boulardii - 50mg 50mg Capsule 381,651 L.L
A07FA02 ULTRA LEVURE B Saccharomyces boulardii - 200mg 200mg Capsule 513,348 L.L
A07FA02 ULTRA LEVURE B Saccharomyces boulardii - 100mg 100mg Powder for suspension 536,193 L.L
J01MA12 ULTRAFLOX 500 G Levofloxacin (hemihydrate) - 500mg 500mg Tablet 1,100,413 L.L
B05AA01 UMAN ALBUMIN BioHuman Albumin human - 20g/100ml 10g/50ml Injectable solution 3,598,810 L.L
J02AC01 UNAZOL G Fluconazole - 150mg 150mg Capsule 149,742 L.L
A08AB01 UNI-CAL G Orlistat - 120mg 120mg Capsule 1,174,518 L.L
R03DC03 UNICAST G Montelukast (sodium) - 5mg 5mg Tablet, chewable 783,460 L.L
R03DC03 UNICAST G Montelukast (sodium) - 10mg 10mg Tablet, film coated 802,274 L.L
R03DC03 UNICAST G Montelukast (sodium) - 4mg 4mg Tablet, chewable 783,460 L.L
L01XX05 UNIDREA G Hydroxycarbamide (or Hydroxyurea) - 500mg 500mg Capsule, hard 2,539,862 L.L
A10BG03 UNIGLIT G Pioglitazone HCl - 15mg 15mg Tablet 685,360 L.L
C02CA04 UNIPROST G Doxazosin - 4mg 4mg Tablet 452,875 L.L
N06AB05 UNIROX G Paroxetine (HCl) - 20mg 20mg Tablet, film coated 854,684 L.L
J02AC01 UNIZOL MS G Fluconazole - 200mg/100ml 200mg/100ml Injectable solution 1,419,098 L.L
B01AC27 UPTRAVI B Selexipag - 200mcg 200mcg Tablet, film coated 242,569,645 L.L
B01AC27 UPTRAVI B Selexipag - 200mcg 200mcg Tablet, film coated 552,391,145 L.L
B01AC27 UPTRAVI B Selexipag - 400mcg 400mcg Tablet, film coated 242,569,645 L.L
B01AC27 UPTRAVI B Selexipag - 600mcg 600mcg Tablet, film coated 242,569,645 L.L
    1
Sitemap
© Copyrights reserved to Ministry of Public Health 2026